Director, Oncology Clinical Affairs (MD)

Responsibilities:

• Partner with Medical Affairs leadership to support the execution of medical priorities related to product adoption and long-term integration into clinical practice. Serve as the primary clinical bridge between Clinical Development and go-to-market teams, ensuring clinical expertise is available to support Medical Affairs, Commercial, Market Access, HEOR, and Regulatory activities

• Provide clinical and medical/scientific expertise to support medical affairs priorities, tactical planning, internal training, advisory boards, congress activities, and cross-functional initiatives that advance product adoption and integration into clinical practice

• Identify areas of unmet medical need and work cross-functionally to translate scientific insights into practical clinical guidance that supports physicians, patients, and internal decision-making

• Model and promote Corcept’s key principles, collaborating effectively, embracing possibilities, following the data, and leading by doing, to build a culture of accountability, innovation, and trust

Scientific Engagement and External Leadership

• Lead high-level peer-to-peer scientific interactions with oncology experts, key opinion leaders (KOLs), clinical researchers, academic centers, and other external medical stakeholders

• Build credibility through balanced scientific exchange around the company’s assets, disease areas, emerging data, unmet needs, and evolving standards of care

• Engage physicians and oncology experts through advisory boards, congress interactions, speaker preparation, and insight-gathering activities to inform medical strategy, education, publications, and evidence planning

• Represent Corcept at key medical conferences and external events as an internal clinical expert and external medical ambassador

Evidence Generation and Data Communication

• Provide clinical input to post-approval evidence generation activities, including real-world evidence (RWE), investigator sponsored studies (ISS), registries, and other data-generation activities that address clinically meaningful evidence gaps

• Provide clinical review and input into ISS proposals and collaborate with Medical Affairs partners on program design, prioritization, and governance

• Evaluate scientific data, clinical trial results, post-marketing evidence, medical literature, and emerging oncology practice trends to inform internal strategy and external scientific communications

• Support development of accurate, balanced, and compliant scientific, educational, medical information, and promotional review materials in partnership with Medical, Legal, Regulatory, Commercial, and Compliance stakeholders

Guideline, Pathway, and Payer-Facing Scientific Support

• Provide perspectives in interpreting, anticipating, and influencing clinical guideline updates and treatment pathways, including NCCN, ASCO, and other relevant oncology contexts

• Engage external experts and stakeholders to support appropriate representation of the company’s data in guidelines and treatment pathways translate guideline and pathway changes into clear clinical and business-relevant implications for internal teams

• Partner with Market Access and HEOR teams to align the clinical narrative with payer value propositions, including outcomes, comparative effectiveness, and economic value

• Participate in payer-facing discussions when deep clinical expertise is required, ensuring scientific alignment, balanced communication, and compliance with internal standards

Safety and Supportive Care Guidance

• Partner with Pharmacovigilance, Clinical Development, and Medical Affairs to develop, refine, and communicate safety-related clinical guidance for assigned asset(s)

• Translate emerging safety data, post-marketing reports, and clinical trial safety findings into practical clinician-facing recommendations, including monitoring strategies, risk mitigation approaches, and adverse event management algorithms

• Contribute to supportive care guidance that optimizes patient tolerability and continuity of therapy while aligning with regulatory requirements, internal safety governance, and real-world oncology practice

• Support safety-related external communications, including responses to KOL inquiries, advisory boards, congress interactions, and other scientific exchanges, while ensuring consistency, balance, and compliance

Preferred Skills, Qualifications and Technical Proficiencies:

• Demonstrated ability to evaluate scientific data, clinical literature, evolving treatment pathways, and oncology practice trends and apply insights to medical, launch, market access, and evidence-generation activities

• Understanding of the U.S. healthcare environment, health technology assessment (HTA) considerations, payer evidence needs, and the pharmaceutical/biotechnology industry

• Strong oral, written, and presentation skills, with the ability to communicate complex clinical concepts clearly to internal and external audiences

• Collaborative, cross-functional leadership style with sound judgment, scientific rigor, and the ability to operate effectively in a launch-focused, evolving environment

• Ability to travel 25-30% or as needed

• MD required

• Oncology experience required; gynecologic oncology experience preferred

• 3-5+ years of relevant oncology practice (including fellowship)

• Experience engaging oncology experts, interpreting clinical evidence, and translating complex data into clear scientific and clinical communications